Cleveland BioLabs (CBLI) Continues Higher On Radiation Threat in Japan
Tweet
Share
E-mailGet Alerts CBLI Hot Sheet
Join SI Premium – FREE
Nuclear radiation play Cleveland BioLabs, Inc. (Nasdaq: CBLI) is up 11 percent this morning after jumping 10 percent yesterday as the situation in Japan deteriorates.
Cleveland Biolabs, Inc. engages in the discovery, development, and commercialization of products for cancer treatment and protection of normal tissues from radiation and other acute stresses.
Cleveland Biolabs, Inc. engages in the discovery, development, and commercialization of products for cancer treatment and protection of normal tissues from radiation and other acute stresses.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman flags 2 Japanese tech stocks to buy
- Barclays flags an "attractive entry point" in this pharma stock
- Morgan Stanley is bullish on this green energy stock
Create E-mail Alert Related Categories
Momentum MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
